Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …

Malignant pleural effusion (MPE) is a sign of advanced cancer and is associated with
significant symptom burden and mortality. To date, management has been palliative in …

Background Malignant pleural effusion (MPE) causes debilitating breathlessness and
predicting survival is challenging. This study aimed to obtain contemporary data on survival …

Background The approach to palliative treatment of malignant pleural effusion (MPE) should
be individualized because these patients generally have poor survival. Our study aimed to …

Simple Summary Malignant pleural mesothelioma is a rare and aggressive tumour,
associated with asbestos exposure. Current therapeutic approaches for malignant …

Summary Background/Purpose Malignant pleural effusion is a frequent situation in
pulmonary medicine. However, it is sometimes difficult to recognize the underlying etiology …

Simple Summary The pleura is a cavity whose pathology ranges from simple fluid
accumulation to tumor development, all inducing important consequences in patents health …

Predicting survival of patients with malignant pleural effusions (MPEs) is notoriously difficult.
A robust prognostic marker can guide clinical decision making. The neutrophil-to …

Background: Patients with malignant pleural effusion (MPE) secondary to lung cancer have
been associated with poor prognosis historically. LENT score developed to risk-stratify …

Malignant pleural effusion (MPE) is a common complication of thoracic and extrathoracic
malignancies and is associated with high mortality. Treatment is mainly palliative, with …